282 related articles for article (PubMed ID: 22095251)
21. Clinical implementation of pharmacogenetics and personalized drug prescription based on e-health: the MedeA initiative.
LLerena A; Peñas-LLedó E; de Andrés F; Mata-Martín C; Sánchez CL; Pijierro A; Cobaleda J
Drug Metab Pers Ther; 2020 Sep; ():. PubMed ID: 32877361
[No Abstract] [Full Text] [Related]
22. Corrigendum to: "Pharmacogenetic testing in psychiatry: Perspective on clinical utility" [Asian J. Psychiatry 86 (2023) 103674].
Adiukwu F; Adesokun O; Essien E; Yalcin N; Ransing R; Nagendrappa S; Jatchavala C; Omotoso ABO; Nawaz FA; Khan N
Asian J Psychiatr; 2023 Nov; 89():103753. PubMed ID: 37647786
[No Abstract] [Full Text] [Related]
23. Exploring Pharmacogenetic Testing for Hypertension Management in China.
Zhao Z; Zhou M
China CDC Wkly; 2023 Sep; 5(35):785-787. PubMed ID: 37745264
[No Abstract] [Full Text] [Related]
24. Implementation and utilization of genetic testing in personalized medicine.
Abul-Husn NS; Owusu Obeng A; Sanderson SC; Gottesman O; Scott SA
Pharmgenomics Pers Med; 2014; 7():227-40. PubMed ID: 25206309
[TBL] [Abstract][Full Text] [Related]
25. Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.
Johnson JA; Burkley BM; Langaee TY; Clare-Salzler MJ; Klein TE; Altman RB
Clin Pharmacol Ther; 2012 Oct; 92(4):437-9. PubMed ID: 22910441
[TBL] [Abstract][Full Text] [Related]
26. Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.
Hicks JK; Swen JJ; Thorn CF; Sangkuhl K; Kharasch ED; Ellingrod VL; Skaar TC; Müller DJ; Gaedigk A; Stingl JC;
Clin Pharmacol Ther; 2013 May; 93(5):402-8. PubMed ID: 23486447
[TBL] [Abstract][Full Text] [Related]
27. The genetics of drug efficacy: opportunities and challenges.
Nelson MR; Johnson T; Warren L; Hughes AR; Chissoe SL; Xu CF; Waterworth DM
Nat Rev Genet; 2016 Apr; 17(4):197-206. PubMed ID: 26972588
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomics knowledge for personalized medicine.
Whirl-Carrillo M; McDonagh EM; Hebert JM; Gong L; Sangkuhl K; Thorn CF; Altman RB; Klein TE
Clin Pharmacol Ther; 2012 Oct; 92(4):414-7. PubMed ID: 22992668
[TBL] [Abstract][Full Text] [Related]
29. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
[TBL] [Abstract][Full Text] [Related]
30. Applications of CYP450 testing in the clinical setting.
Samer CF; Lorenzini KI; Rollason V; Daali Y; Desmeules JA
Mol Diagn Ther; 2013 Jun; 17(3):165-84. PubMed ID: 23588782
[TBL] [Abstract][Full Text] [Related]
31. Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Dunnenberger HM; Crews KR; Hoffman JM; Caudle KE; Broeckel U; Howard SC; Hunkler RJ; Klein TE; Evans WE; Relling MV
Annu Rev Pharmacol Toxicol; 2015; 55():89-106. PubMed ID: 25292429
[TBL] [Abstract][Full Text] [Related]
32. Implementation of pharmacogenetics: the University of Maryland Personalized Anti-platelet Pharmacogenetics Program.
Shuldiner AR; Palmer K; Pakyz RE; Alestock TD; Maloney KA; O'Neill C; Bhatty S; Schub J; Overby CL; Horenstein RB; Pollin TI; Kelemen MD; Beitelshees AL; Robinson SW; Blitzer MG; McArdle PF; Brown L; Jeng LJ; Zhao RY; Ambulos N; Vesely MR
Am J Med Genet C Semin Med Genet; 2014 Mar; 166C(1):76-84. PubMed ID: 24616408
[TBL] [Abstract][Full Text] [Related]
33. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.
Shuldiner AR; Relling MV; Peterson JF; Hicks JK; Freimuth RR; Sadee W; Pereira NL; Roden DM; Johnson JA; Klein TE; ; Shuldiner AR; Vesely M; Robinson SW; Ambulos N; Stass SA; Kelemen MD; Brown LA; Pollin TI; Beitelshees AL; Zhao RY; Pakyz RE; Palmer K; Alestock T; O'Neill C; Maloney K; Branham A; Sewell D; Relling MV; Crews K; Hoffman J; Cross S; Haidar C; Baker D; Hicks JK; Bell G; Greeson F; Gaur A; Reiss U; Huettel A; Cheng C; Gajjar A; Pappo A; Howard S; Hudson M; Pui CH; Jeha S; Evans WE; Broeckel U; Altman RB; Gong L; Whirl-Carrillo M; Klein TE; Sadee W; Manickam K; Sweet KM; Embi PJ; Roden D; Peterson J; Denny J; Schildcrout J; Bowton E; Pulley J; Beller M; Mitchell J; Danciu I; Price L; Pereira NL; Weinshilboum R; Wang L; Johnson JA; Nelson D; Clare-Salzler M; Elsey A; Burkley B; Langaee T; Liu F; Nessl D; Dong HJ; Lesko L; Freimuth RR; Chute CG
Clin Pharmacol Ther; 2013 Aug; 94(2):207-10. PubMed ID: 23588301
[TBL] [Abstract][Full Text] [Related]
34. The potential utility of pharmacogenetic testing in psychiatry.
Gardner KR; Brennan FX; Scott R; Lombard J
Psychiatry J; 2014; 2014():730956. PubMed ID: 25587529
[TBL] [Abstract][Full Text] [Related]
35. From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.
Fabbri C; Porcelli S; Serretti A
Can J Psychiatry; 2014 Feb; 59(2):62-75. PubMed ID: 24881125
[TBL] [Abstract][Full Text] [Related]
36. Positive perception of pharmacogenetic testing for psychotropic medications.
Lanktree MB; Zai G; Vanderbeek LE; Giuffra DE; Smithson DS; Kipp LB; Dalseg TR; Speechley M; Kennedy JL
Hum Psychopharmacol; 2014 May; 29(3):287-91. PubMed ID: 24604560
[TBL] [Abstract][Full Text] [Related]
37. Next-generation medicines: past regulatory experience and considerations for the future.
Pacanowski MA; Leptak C; Zineh I
Clin Pharmacol Ther; 2014 Mar; 95(3):247-9. PubMed ID: 24548989
[TBL] [Abstract][Full Text] [Related]
38. Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.
Caudle KE; Klein TE; Hoffman JM; Muller DJ; Whirl-Carrillo M; Gong L; McDonagh EM; Sangkuhl K; Thorn CF; Schwab M; Agundez JA; Freimuth RR; Huser V; Lee MT; Iwuchukwu OF; Crews KR; Scott SA; Wadelius M; Swen JJ; Tyndale RF; Stein CM; Roden D; Relling MV; Williams MS; Johnson SG
Curr Drug Metab; 2014 Feb; 15(2):209-17. PubMed ID: 24479687
[TBL] [Abstract][Full Text] [Related]
39. Clinical implementation of genetic testing in medicine: a US regulatory science perspective.
Lesko LJ; Schmidt S
Br J Clin Pharmacol; 2014 Apr; 77(4):606-11. PubMed ID: 24286486
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetic testing: Current Evidence of Clinical Utility.
Moaddeb J; Haga SB
Ther Adv Drug Saf; 2013 Aug; 4(4):155-169. PubMed ID: 24020014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
